To condition or not condition? Analysing 'change' in longitudinal randomised controlled trials

被引:130
作者
Coffman, Cynthia J. [1 ,2 ]
Edelman, David [1 ,3 ]
Woolson, Robert F. [1 ,2 ]
机构
[1] Durham Vet Affairs Med Ctr, Hlth Serv Res, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27708 USA
[3] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
关键词
CLINICAL-TRIALS; BASE-LINE; MEDICAL CLINICS; MISSING DATA; COVARIANCE; STATISTICS;
D O I
10.1136/bmjopen-2016-013096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The statistical analysis for a 2-arm randomised controlled trial (RCT) with a baseline outcome followed by a few assessments at fixed follow-up times typically invokes traditional analytic methods (eg, analysis of covariance (ANCOVA), longitudinal data analysis (LDA)). 'Constrained' longitudinal data analysis (cLDA) is a well-established unconditional technique that constrains means of baseline to be equal between arms. We use an analysis of fasting lipid profiles from the Group Medical Clinics (GMC) longitudinal RCT on patients with diabetes to illustrate applications of ANCOVA, LDA and cLDA to demonstrate theoretical concepts of these methods including the impact of missing data. Methods: For the analysis of the illustrated example, all models were fit using linear mixed models to participants with only complete data and to participants using all available data. Results: With complete data (n=195), 95% CI coverage are equivalent for ANCOVA and cLDA with an estimated 11.2 mg/dL (95% CI -19.2 to -3.3; p=0.006) lower mean low-density lipoprotein (LDL) cholesterol in GMC compared with usual care. With all available data (n=233), applying the cLDA model yielded an LDL improvement of 8.9 mg/dL (95% CI -16.7 to -1.0; p=0.03) for GMC compared with usual care. The less efficient, LDA analysis yielded an LDL improvement of 7.2 mg/dL (95% CI -17.2 to 2.8; p=0.15) for GMC compared with usual care. Conclusions: Under reasonable missing data assumptions, cLDA will yield efficient treatment effect estimates and robust inferential statistics. It may be regarded as the method of choice over ANCOVA and LDA.
引用
收藏
页数:6
相关论文
共 19 条
[1]   ANALYSIS OF COVARIANCE IN PARALLEL-GROUP CLINICAL-TRIALS WITH PRETREATMENT BASELINES [J].
CRAGER, MR .
BIOMETRICS, 1987, 43 (04) :895-901
[2]   Can Group Medical Clinics Improve Lipid Management in Diabetes? [J].
Crowley, Matthew J. ;
Melnyk, Stephanie D. ;
Ostroff, Jared L. ;
Fredrickson, Sonja K. ;
Jeffreys, Amy S. ;
Coffman, Cynthia J. ;
Edelman, David .
AMERICAN JOURNAL OF MEDICINE, 2014, 127 (02) :145-151
[3]   Medical Clinics Versus Usual Care for Patients With Both Diabetes and Hypertension A Randomized Trial [J].
Edelman, David ;
Fredrickson, Sonja K. ;
Melnyk, Stephanie D. ;
Coffman, Cynthia J. ;
Jeffreys, Amy S. ;
Datta, Santanu ;
Jackson, George L. ;
Harris, Amy C. ;
Hamilton, Natia S. ;
Stewart, Helen ;
Stein, Jeannette ;
Weinberger, Morris .
ANNALS OF INTERNAL MEDICINE, 2010, 152 (11) :689-W287
[4]   Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study [J].
Egbewale, Bolaji E. ;
Lewis, Martyn ;
Sim, Julius .
BMC MEDICAL RESEARCH METHODOLOGY, 2014, 14
[5]  
Fitzmaurice G., 2011, Applied Longitudinal Data Analysis, V2nd
[6]   Addressing Missing Data in Clinical Trials [J].
Fleming, Thomas R. .
ANNALS OF INTERNAL MEDICINE, 2011, 154 (02) :113-+
[7]   REPEATED MEASURES IN CLINICAL-TRIALS - ANALYSIS USING MEAN SUMMARY STATISTICS AND ITS IMPLICATIONS FOR DESIGN [J].
FRISON, L ;
POCOCK, SJ .
STATISTICS IN MEDICINE, 1992, 11 (13) :1685-1704
[8]   Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? [J].
Kenward, Michael G. ;
White, Ian R. ;
Carpenter, James R. .
STATISTICS IN MEDICINE, 2010, 29 (13) :1455-1456
[9]  
Liang KY., 2000, Sankhya: The Indian Journal of Statistics, Series B, V62, P134, DOI DOI 10.2307/25053123
[10]  
Little R. J., 2019, Statistical analysis with missing data, V793